IRIS Accounts Production v25.2.0.378 07607573 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false Ordinary 1.00000 Ordinary A 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh076075732024-03-31076075732025-03-31076075732024-04-012025-03-31076075732023-03-31076075732023-04-012024-03-31076075732024-03-3107607573ns15:EnglandWales2024-04-012025-03-3107607573ns14:PoundSterling2024-04-012025-03-3107607573ns10:Director12024-04-012025-03-3107607573ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3107607573ns10:SmallEntities2024-04-012025-03-3107607573ns10:AuditExemptWithAccountantsReport2024-04-012025-03-3107607573ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3107607573ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107607573ns10:FullAccounts2024-04-012025-03-3107607573ns10:OrdinaryShareClass12024-04-012025-03-3107607573ns10:OrdinaryShareClass22024-04-012025-03-3107607573ns10:Director22024-04-012025-03-3107607573ns10:RegisteredOffice2024-04-012025-03-3107607573ns5:CurrentFinancialInstruments2025-03-3107607573ns5:CurrentFinancialInstruments2024-03-3107607573ns5:ShareCapital2025-03-3107607573ns5:ShareCapital2024-03-3107607573ns5:RetainedEarningsAccumulatedLosses2025-03-3107607573ns5:RetainedEarningsAccumulatedLosses2024-03-3107607573ns5:LandBuildingsns5:ShortLeaseholdAssets2024-03-3107607573ns5:PlantMachinery2024-03-3107607573ns5:FurnitureFittings2024-03-3107607573ns5:ComputerEquipment2024-03-3107607573ns5:LandBuildingsns5:ShortLeaseholdAssets2024-04-012025-03-3107607573ns5:PlantMachinery2024-04-012025-03-3107607573ns5:FurnitureFittings2024-04-012025-03-3107607573ns5:ComputerEquipment2024-04-012025-03-3107607573ns5:LandBuildingsns5:ShortLeaseholdAssets2025-03-3107607573ns5:PlantMachinery2025-03-3107607573ns5:FurnitureFittings2025-03-3107607573ns5:ComputerEquipment2025-03-3107607573ns5:LandBuildingsns5:ShortLeaseholdAssets2024-03-3107607573ns5:PlantMachinery2024-03-3107607573ns5:FurnitureFittings2024-03-3107607573ns5:ComputerEquipment2024-03-3107607573ns5:UnlistedNon-exchangeTradedns5:CostValuation2024-03-3107607573ns5:UnlistedNon-exchangeTraded2025-03-3107607573ns5:UnlistedNon-exchangeTraded2024-03-3107607573ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3107607573ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3107607573ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2025-03-3107607573ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2024-03-3107607573ns5:DeferredTaxation2024-03-3107607573ns5:DeferredTaxation2024-04-012025-03-3107607573ns5:DeferredTaxation2025-03-3107607573ns10:OrdinaryShareClass12025-03-3107607573ns10:OrdinaryShareClass22025-03-3107607573ns5:RetainedEarningsAccumulatedLosses2024-03-3107607573ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-31
REGISTERED NUMBER: 07607573 (England and Wales)















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

THE KB CLINIC LIMITED

THE KB CLINIC LIMITED (REGISTERED NUMBER: 07607573)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Accountants' Report 9

THE KB CLINIC LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: Dr K Bush
Mrs R D'Angiolino





REGISTERED OFFICE: 75 Harley Street
Suite 3
London
W1G 8QL





REGISTERED NUMBER: 07607573 (England and Wales)





ACCOUNTANTS: MGR Paris Limited
Chartered Accountants
55 Loudoun Road
St John's Wood
London
NW8 0DL

THE KB CLINIC LIMITED (REGISTERED NUMBER: 07607573)

BALANCE SHEET
31 MARCH 2025

31.3.25 31.3.24
Notes £    £   
FIXED ASSETS
Tangible assets 4 45,376 58,545
Investments 5 34,998 34,998
80,374 93,543

CURRENT ASSETS
Debtors 6 298,638 322,032
Cash at bank and in hand 1,572,858 1,500,080
1,871,496 1,822,112
CREDITORS
Amounts falling due within one year 7 (66,913 ) (72,404 )
NET CURRENT ASSETS 1,804,583 1,749,708
TOTAL ASSETS LESS CURRENT LIABILITIES 1,884,957 1,843,251

PROVISIONS FOR LIABILITIES 8 (8,061 ) (11,163 )
NET ASSETS 1,876,896 1,832,088

CAPITAL AND RESERVES
Called up share capital 9 2,000 2,000
Retained earnings 10 1,874,896 1,830,088
SHAREHOLDERS' FUNDS 1,876,896 1,832,088

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

THE KB CLINIC LIMITED (REGISTERED NUMBER: 07607573)

BALANCE SHEET - continued
31 MARCH 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 May 2025 and were signed on its behalf by:





Dr K Bush - Director


THE KB CLINIC LIMITED (REGISTERED NUMBER: 07607573)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

The KB Clinic Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The monetary amounts are rounded to the nearest pound.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings - 25% on reducing balance
Plant and machinery - 25% on reducing balance
Computer equipment - 33% on straight line
Leasehold - 15 year straight line

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

THE KB CLINIC LIMITED (REGISTERED NUMBER: 07607573)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued

Basic financial assets
Basic financial assets, which include trade and other debtors and cash and bank balances, are initially measured at transaction price including transaction and where material are subsequently measured at amortise cost using the effective interest method, less any impairment

Impairment of financial assets
Financial assets, other than those held at fair value are assessed for indicators or impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occured after the initial recognition of the financial asset, the estimated future cash flows have been affected. The impairment loss is recognised in the Statement of Total Comprehensive Income.

Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire, or when it transfer the financial asset and substantially all the risks and rewards of ownership to another entity.

Basic financial liabilities
Basic financial liabilities, including trade and other payables and loans from company undertakings that are classified as debt are initially measured at transaction price unless the arrangement constitute a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at the market rate of interest.

Trade creditors are obligations to pay for goods or services that have been acquired int he ordinary course of business from suppliers. Accounts payables are classified as current liabilities if a payment is due within one year or less. If not, they are present as non current liabilities. Short term creditors are initially recognised at transaction price and where material are subsequently measured at amortised cost using the effective interest method.

Cash and cash equivalent
Cash and cash equivalent include cash in hand, deposits held at call with banks, other short term liquid investments with original maturities of three months or less.

Leases
Assets acquired under hire purchase agreements are capitalised and depreciated over the shorter of the lease term and the expected useful life of the asset. Minimum lease payments are apportioned between the finance charge and the reduction of the outstanding liability using the effective interest method. The related obligations, net of future finance charges, are included in creditors.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

THE KB CLINIC LIMITED (REGISTERED NUMBER: 07607573)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
Leasehold machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 April 2024 17,364 43,978 21,663 25,743 108,748
Additions - - - 1,498 1,498
At 31 March 2025 17,364 43,978 21,663 27,241 110,246
DEPRECIATION
At 1 April 2024 3,473 11,199 12,618 22,913 50,203
Charge for year 1,158 8,264 2,261 2,984 14,667
At 31 March 2025 4,631 19,463 14,879 25,897 64,870
NET BOOK VALUE
At 31 March 2025 12,733 24,515 6,784 1,344 45,376
At 31 March 2024 13,891 32,779 9,045 2,830 58,545

5. FIXED ASSET INVESTMENTS
Unlisted
investments
£   
COST
At 1 April 2024
and 31 March 2025 34,998
NET BOOK VALUE
At 31 March 2025 34,998
At 31 March 2024 34,998

Entity Country of Incorporation Class Ownership
Daynart Limited Scotland Equity 1%

6. DEBTORS
31.3.25 31.3.24
£    £   
Amounts falling due within one year:
Trade debtors 1,605 5,516
Other debtors 61,433 80,916
63,038 86,432

THE KB CLINIC LIMITED (REGISTERED NUMBER: 07607573)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


6. DEBTORS - continued
31.3.25 31.3.24
£    £   
Amounts falling due after more than one year:
Other debtors 235,600 235,600

Aggregate amounts 298,638 322,032

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Taxation and social security 14,652 17,394
Other creditors 52,261 55,010
66,913 72,404

8. PROVISIONS FOR LIABILITIES
31.3.25 31.3.24
£    £   
Deferred tax 8,061 11,163

Deferred
tax
£   
Balance at 1 April 2024 11,163
Provided during year (3,102 )
Balance at 31 March 2025 8,061

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.25 31.3.24
value: £    £   
1,000 Ordinary £1 1,000 1,000
1,000 Ordinary A £1 1,000 1,000
2,000 2,000

THE KB CLINIC LIMITED (REGISTERED NUMBER: 07607573)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


10. RESERVES
Retained
earnings
£   

At 1 April 2024 1,830,088
Profit for the year 44,808
At 31 March 2025 1,874,896

ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
THE KB CLINIC LIMITED


The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of The KB Clinic Limited for the year ended 31 March 2025 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of The KB Clinic Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of The KB Clinic Limited and state those matters that we have agreed to state to the Board of Directors of The KB Clinic Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than The KB Clinic Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that The KB Clinic Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of The KB Clinic Limited. You consider that The KB Clinic Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of The KB Clinic Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






MGR Paris Limited
Chartered Accountants
55 Loudoun Road
St John's Wood
London
NW8 0DL


28 May 2025